2022 Norton Education Series: Irritable Bowel Syndrome Event
Resident Sponsor: Ardelyx
“Here at Ardelyx®, we are dedicated to improving the lives of patients by discovering, developing and commercializing first-in-class targeted therapies that advance patient care. Using our discovery model, Ardelyx scientists identified new biological mechanisms and pathways that enabled us to develop drug candidates designed to address significant unmet medical needs with the goal of improving outcomes for patients.”
